On July 2, Celsius Holdings rose 5.22% in regular trading, trading at $33.585/share, with turnover of $57.82 million.

On the news front, UBS recently published a research note indicating that Celsius' core business deceleration is largely in line with management expectations, as the company progresses through SKU rationalization and gains incremental market share. UBS lowered its price target from $55 to $50 but maintained its Buy rating, implying approximately 49% upside from current levels. FactSet consensus among analysts shows a mean price target of $59.32, suggesting the market has largely priced in the business slowdown.

The stock also continues to benefit from Q1 earnings that beat expectations, with adjusted EPS of $0.41 versus estimates of around $0.30, and revenue of $782.6 million surpassing the consensus estimate of approximately $763 million. These factors collectively provided support for the rebound in share price.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)